Bausch Health Companies (BHC) Interest Coverage Ratio Growth (3y) (2012 - 2026)
Bausch Health Companies (BHC) Interest Coverage Ratio Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 17.14% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 0.23% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -28.01% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -32.31% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 26.99% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 41.72% |
| 10 | Bausch Health Companies | 1.66 Bn | 1.33 Bn | 2.52 Bn | 44.53% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 44.53% |
| Dec 31, 2025 | 48.51% |
| Sep 30, 2025 | 33.34% |
| Jun 30, 2025 | -8.21% |
| Mar 31, 2025 | 24.90% |
| Dec 31, 2024 | 15.67% |
| Sep 30, 2024 | 9.01% |
| Jun 30, 2024 | 56.51% |
| Mar 31, 2024 | 64.13% |
| Dec 31, 2023 | 303.36% |
| Sep 30, 2023 | -66.49% |
| Jun 30, 2023 | 309.24% |
| Mar 31, 2023 | 35.02% |
| Dec 31, 2022 | -38.51% |
| Sep 30, 2022 | 33.10% |
| Jun 30, 2022 | 5.34% |
| Mar 31, 2022 | 22.76% |
| Dec 31, 2021 | 156.43% |
| Sep 30, 2021 | 104.10% |
| Jun 30, 2021 | -48.41% |